Assessing Long-term Treatment Benefits Using Complementary Statistical Approaches: An In Silico Analysis of the Phase III Keynote-045 and Checkmate-214 Immune Checkpoint Inhibitor Trials-Reference-Cited by-同舟云学术

Assessing Long-term Treatment Benefits Using Complementary Statistical Approaches: An In Silico Analysis of the Phase III Keynote-045 and Checkmate-214 Immune Checkpoint Inhibitor Trials

Published:2023-02 Issue: Volume: Page:
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Cavillon Ana,Pouessel Damien,Houédé Nadine,Mathevet Fanny,Dauxois Jean Yves,Chevreau Christine,Culine Stéphane,Delord Jean-Pierre,Porcher Raphael,Filleron Thomas^ORCID

Publisher

Elsevier BV

Subject

Urology

Reference31 articles.

1. Immune checkpoint inhibitor combinations in solid tumors: opportunities and challenges;Kyi;Immunotherapy,2016

2. Pembrolizumab as second-line therapy for advanced urothelial carcinoma;Bellmunt;N Engl J Med,2017

3. Randomized phase III KEYNOTE-045 trial of pembrolizumab versus paclitaxel, docetaxel, or vinflunine in recurrent advanced urothelial cancer: results of >2 years of follow-up;Fradet;Ann Oncol,2019

5. Methods for accommodating nonproportional hazards in clinical trials: ready for the primary analysis?;Freidlin;J Clin Oncol,2019

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Toripalimab in combination with chemotherapy effectively suppresses local recurrence and metastatic sarcomatoid renal cell carcinoma: A case report;World Journal of Clinical Cases;2024-10-06

2. Reply to Binghao Zhao, Ruidong Zhang, and Jiaming Wu’s Letter to the Editor re: Ana Cavillon, Damien Pouessel, Nadine Houédé, et al. Assessing Long-term Treatment Benefits Using Complementary Statistical Approaches: An In Silico Analysis of the Phase III Keynote-045 and Checkmate-214 Immune Checkpoint Inhibitor Trials. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2023.02.011;European Urology;2023-07

3. Re: Ana Cavillon, Damien Pouessel, Nadine Houédé, et al. Assessing Long-term Treatment Benefits Using Complementary Statistical Approaches: An In Silico Analysis of the Phase III Keynote-045 and Checkmate-214 Immune Checkpoint Inhibitor Trials. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2023.02.011;European Urology;2023-07